emphasised following paediatric guidelines, which do include pharmacological treatment at
certain thresholds. 9, 10 All guidelines agree on the importance of intensive glucose control …

1 Rawshani A, Sattar N, Franzén S, et al. Excess mortality and cardiovascular disease in
young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based …

1 Rawshani A, Sattar N, Franzén S, et al. Excess mortality and cardiovascular disease in
young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based …

Therapeutic options for diabetes have improved, allowing people with type 1 diabetes to live
longer and healthier lives. However, life expectancy remains 8–13 years shorter and …

Comment 88 www. thelancet. com/diabetes-endocrinology Vol 4 February 2016 diabetes
done so far, this observation is robust and confirms the findings of a similar study from Hong …

Sebastian Kaulitzki/Science Photo Library duration and long-term glycaemia. As such, with
its younger population, we seem generally to be more concerned about microvascular …

In their Seminar on type 2 diabetes, Ehtasham Ahmad and colleagues1 highlighted the
current and future global burden of disease and correctly stated that the increased risk of …

We read with interest the findings of Sarah Lewington and colleagues1 from the Prospective
Studies Collaboration and Asia Pacific Cohort Studies Collaboration on the sex-specific …

In The Lancet Diabetes & Endocrinology, Dianna Magliano and colleagues1 assess trends
in all-cause mortality from 1995 to 2016 among people with and without diabetes from 19 …

Type 1 and type 2 diabetes mellitus are both associated with an increased risk of
cardiovascular disease. 1–3 In this Issue of the Lancet Regional Health—Europe, two cohort …